Integrated Biosciences Announces Nature Publication Identifying New Class Of Antibiotics Discovered Via Company’s Ai-powered Platform

Integrated Biosciences, a biotechnology company, has announced the publication of a peer-reviewed manuscript in the journal Nature detailing the application of its platform in the discovery of a new class of small molecule antibiotics capable of addressing antibiotic resistance. This discovery is the first of its kind leveraging an AI-powered platform built around explainable deep learning and is one of the first new classes of antibiotics in the past 60 years. The paper was co-authored by a team of 21 researchers, led by Felix Wong, Ph.D., and James J. Collins, Ph.D.